FDA Press Release

Title Picture
12/15/2017 - 08:17
Teva Announces Exclusive Launch of Generic Viread in the United States
Teva Pharmaceutical's picture
Teva Pharmaceutical
12/14/2017 - 14:45
Dr. Mohamad Cherry, Award-Winning Clinician, Educator and Researcher in Blood and Bone Cancers, Joins Atlantic Hematology Oncology
Atlantic Health System's picture
Atlantic Health...
12/13/2017 - 08:09
2018 Holiday Press Release
AAPCCAmerican Association of Poison Control Center...'s picture
AAPCC
12/13/2017 - 06:28
Going after opioid manufacturers, distributors in court may help with crisis
University of Michigan's picture
University of M...
12/13/2017 - 00:31
Genomic blood test predicts survival rates after surgery for advanced heart failure
University of California Los Angeles's picture
UCLA
12/13/2017 - 00:09
AG Schimel and UW System Team Up with Adapt Pharma to Expand Narcan Availability on University Campuses
University of Wisconsin System's picture
University of W...
12/12/2017 - 23:51
FDA launches new tool for sharing information that allows doctors to better manage antibiotic use; improve patient care
Food and Drug Administration's picture
FDA
12/12/2017 - 23:18
FDA Approves New Pfizer Biosimilar
Pfizer's picture
Pfizer
12/12/2017 - 22:22
Sanofi and Regeneron announce positive topline pivotal results for PD-1 antibody cemiplimab in advanced cutaneous squamous cell carcinoma
Genzyme's picture
Genzyme
12/12/2017 - 16:16
Bachelor's in Biology (BA or BS)
Roosevelt University's picture
Roosevelt University
12/12/2017 - 15:50
University of New Mexico Inventors Elected Fellows of the National Academy of Inventors
University of New Mexico's picture
University of N...
12/12/2017 - 14:42
Mount Sinai Study to Characterize Rare Neurodevelopmental Disorder Tied to Autism
Mount Sinai's picture
Mount Sinai
12/12/2017 - 12:13
Philip Morris International Releases Latest Scientific Update for Smoke-Free Products on Clinical Program
Philip Morris's picture
Philip Morris
12/12/2017 - 11:50
GSK achieves approval for Nucala (mepolizumab) for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) for adults in the US
GlaxoSmithKline's picture
GlaxoSmithKline
12/12/2017 - 10:28
Anaplastic Astrocytoma diagnosis provided motivation for Syracuse football program to tackle rare diseases
Uplifting Athletes's picture
Uplifting Athletes
12/12/2017 - 08:35
FDA warns companies for promoting alternatives to street drugs
Food and Drug Administration's picture
FDA
12/12/2017 - 06:52
Late-Breaking Clinical Trials Signal New Therapeutic Options for Many Patients in the Near Term
American Society of Hematology's picture
American Societ...
12/12/2017 - 05:29
Myriad's BRACAnalysis CDx Test Effectively Identified Metastatic Breast Cancer Patients with Improved Outcomes from Pfizer's PARP Inhibitor, Talazoparib
Myriad's picture
Myriad
12/11/2017 - 11:48
CEL-SCI REACHES FULL ENROLLMENT IN PIVOTAL PHASE 3 HEAD AND NECK CANCER STUDY
Cel-Sci's picture
Cel-Sci
12/11/2017 - 11:37
Teva Dismisses Litigation After Mylan Wins U.S. Court Ruling Related to Teva's Cold Filtration Patents for Copaxone 40 mg/mL
Mylan's picture
Mylan
12/11/2017 - 10:29
Results of Phase 1b/2 Dose Regimen Optimization Studies for ALXN1210 in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Presented at American Society of Hematology (ASH) Meeting
Alexion's picture
Alexion
12/11/2017 - 08:32
Rexahn Pharmaceuticals Presents New Preclinical Data on Supinoxin at the 2017 San Antonio Breast Cancer Symposium
Rexahn Pharmaceuticals's picture
Rexahn Pharmace...
12/11/2017 - 08:18
Teva Announces Exclusive Launch of Generic Viagra Tablets in the United States
Teva Pharmaceutical's picture
Teva Pharmaceutical
12/11/2017 - 07:27
Roswell Park Hematology Experts Sharing New Research in ASH 2017 Podium Presentations
Roswell Park Cancer Institute's picture
Roswell Park Ca...
12/11/2017 - 03:49
Save Pets from being Victim to Holiday Dangers
Groff Hinman's picture
Groff Hinman
12/11/2017 - 00:24
Atezolizumab plus Avastin Significantly Improves Progression Free Survival Compared with Sunitinib in PD-L1 Positive Patients for the First-line Treatment of Advanced Renal Cell Carcinoma in the IMmotion151 Study
Chugai's picture
Chugai
12/10/2017 - 11:19
CAR T-Cell Therapies Drive Outcomes in Lymphoma, Myeloma
American Society of Hematology's picture
American Societ...
12/10/2017 - 09:49
Phase II Data Showed Genentechs Investigational Polatuzumab Vedotin Plus Bendamustine and Rituxan (BR) Increased Complete Response Rates Compared to BR Alone in Previously Treated Aggressive Lymphoma
Genentech's picture
Genentech
12/10/2017 - 07:46
New Data for FDA-Approved CAR T Therapy Show Significant Remission Rates in 42% of Non-Hodgkin Lymphoma Patients
Moffitt's picture
Moffitt
12/10/2017 - 05:42
Phase II data showed Roches investigational polatuzumab vedotin plus bendamustine and MabThera/Rituxan (BR) increased complete response rates compared to BR alone in previously treated aggressive lymphoma
Rocheusa's picture
Rocheusa
12/09/2017 - 17:02
Sustained Benefit in Patients with Relapsed/Refractory Mantle Cell Lymphoma Demonstrated by 3-Year Follow-Up Data of IMBRUVICA (ibrutinib)
Johnson and Johnson's picture
Johnson and Johnson
12/09/2017 - 10:22
Genentechs Hemlibra (emicizumab-kxwh) Continued to Substantially Reduce Bleeds in People with Hemophilia A with Inhibitors
Genentech's picture
Genentech
12/09/2017 - 05:14
Roches Hemlibra continued to substantially reduce bleeds in people with haemophilia A with inhibitors
Rocheusa's picture
Rocheusa
12/08/2017 - 13:37
Cytokinetics Announces Presentation of Results From VITALITY-ALS at 28th International Symposium on ALS/MND
Cytokinetics's picture
Cytokinetics
12/08/2017 - 12:31
Researchers Seek Breast Cancer Biomarkers that Indicate Immunotherapy Responsiveness
Fox Chase's picture
Fox Chase
12/07/2017 - 17:56
Nx2me Connected Health Improves Home Hemodialysis Retention
NxStage's picture
NxStage
12/07/2017 - 09:59
Purdue Extension providing statewide training to help growers meet Produce Safety Rule requirements
Purdue University's picture
Purdue
12/07/2017 - 07:28
Vertex Announces Positive Results from Open-Label Phase 3 Study of KALYDECO (ivacaftor) in Children with Cystic Fibrosis Ages 1 to 2 Years
Vertex's picture
Vertex
12/07/2017 - 05:56
Sanofi explores combination treatments for multiple myeloma in new late-stage trials
Genzyme's picture
Genzyme
12/07/2017 - 03:45
Alexion and Halozyme Enter License Agreement for ENHANZE Technology
Halozyme's picture
Halozyme
12/06/2017 - 17:36
Solvay and Apollo Medical see growing interest in Veradel HC A-301 PESUs potential as a game-changing material for medical microtube designs
Solvay's picture
Solvay
12/06/2017 - 11:03
Library Recognized as a Learning Space Transformed
Carnegie Mellon University's picture
CarnegieMellon
12/06/2017 - 02:04
Genentechs HEMLIBRA (emicizumab-kxwh) Every Four Weeks Controlled Bleeds in Phase III Study in Hemophilia A
Genentech's picture
Genentech
12/05/2017 - 21:18
59th ASH Annual Meeting to Celebrate Major Advances in Hematology Research
American Society of Hematology's picture
American Societ...
12/05/2017 - 19:32
FDA approves new drug to prevent a common virus infection in certain cell transplant patients based on research at Dana-Farber/Brigham and Women's Cancer Center
Dana Farber's picture
Dana Farber
12/05/2017 - 18:02
Mount Sinai Surgeons Remove Cancerous Lymph Nodes in the Neck Through Hidden Scar Procedure
Mount Sinai's picture
Mount Sinai
12/05/2017 - 10:45
Moffitt Cancer Center Uses Innovative Treatment Strategy to Overcome Drug Resistance
Moffitt's picture
Moffitt
12/04/2017 - 21:37
Phase 3 Study Evaluating IMBRUVICA (ibrutinib) in Combination with Rituximab in Waldenstroms Macroglobulinemia Met Primary Endpoint
Johnson and Johnson's picture
Johnson and Johnson
12/03/2017 - 20:57
McKesson Specialty Health and US Oncology Research Announce Schedule of Presentations at the 2017 American Society of Hematology Annual Meeting and Exposition
McKesson's picture
McKesson
12/01/2017 - 11:29
Cytokinetics Announces Results of VITALITY-ALS to be Presented at the International Symposium on ALS/MND
Cytokinetics's picture
Cytokinetics
12/01/2017 - 07:54
U.S. FDA Approves Mylan and Biocon's Ogivri, the First Biosimilar for Trastuzumab, for the Treatment of HER2-Positive Breast and Gastric Cancers
Mylan's picture
Mylan
11/30/2017 - 13:24
FDA announces approval, CMS proposes coverage of first breakthrough-designated test to detect extensive number of cancer biomarkers
Centers for Medicare & Medicaid Services's picture
CMS.gov
11/30/2017 - 11:57
European Medicines Agency Accepts Marketing Authorization Applications for Mylan and Biocon's Proposed Biosimilars Trastuzumab and Pegfilgrastim
Mylan's picture
Mylan
11/30/2017 - 04:34
New Publication Shows Respiratory Decline Correlated With Disease Progression in People Living With ALS
Cytokinetics's picture
Cytokinetics
11/30/2017 - 04:07
New Publication Summarizes Phase 1 Studies of CK-2127107 Showing Tolerability and Amplification of Skeletal Muscle Response to Nerve Activation
Cytokinetics's picture
Cytokinetics
11/30/2017 - 01:58
ViiV Healthcare announces start of phase III study of long-acting cabotegravir for HIV prevention in women
GlaxoSmithKline's picture
GlaxoSmithKline
11/29/2017 - 19:50
FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for opioid use disorder
Food and Drug Administration's picture
FDA
11/29/2017 - 19:15
Statement from FDA Commissioner Scott Gottlieb, M.D., on the approval of a new formulation of buprenorphine and FDAs efforts to promote more widespread innovation and access to opioid addiction treatments
Food and Drug Administration's picture
FDA
11/29/2017 - 13:38
Solvay unveils Zeniva ZA-600 CF30 PEEK, a high-strength, injection moldable polymer for implantable devices
Solvay's picture
Solvay
11/28/2017 - 09:12
Virginia Cancer Specialists and The US Oncology Network Welcome Dr. Stephanie Akbari
McKesson's picture
McKesson